The future of cancer precision therapy is here

Tzu measures circulating cancer cells as they travel toward metastatic spread, while we develop therapy to attack these metastasizing cancer cells.

Our company

Tzu Cancer Therapeutics is pioneering the development of precision therapies attacking metastatic cancer, the leading cause of cancer death. 

We are inspired by the Chinese philosopher Sun Tzu (544 - 596 BC), who wrote in the Art of War: “know your enemy and know yourself; in a hundred battles you will never be defeated.” 

Our cancer therapies are based on in-depth knowledge of circulating tumor cells (CTCs), which cause metastasis and are the real enemy. 

TECHNOLOGY

TzuPlus

We established TzuPlus technology to get the deepest understanding of metastasizing cancer cells. TzuPlus maps 3 layers (DNA, mRNA, and surface proteins) for each individual circulating tumor cell.

Our clinically validated approach allows the screening of large blood volumes. A growing database of circulating tumor cell molecular information provides a gateway towards effective cancer precision therapy against metastatic disease.

explore the technology

™

01

Surface proteins

Multiplex surface protein expression analysis​

200x

More circulating tumor cells recovered vs. conventional methods, from clinically validated large-volume blood screening.

02

03

mRNA

Full-length mRNA sequencing of single CTCs​

DNA

Genome-wide mutational profiling of single CTCs​

dr. Wigard Kloosterman

CEO

dr. Ronald Plasterk

Founder & CSO

dr. Michiel Stevens

CTO

Noëlle Beute

COO

dr. Mike Shaw

CBO

dr. Debora Meijer

Bioinformatician

dr. Alberto Gil Jimenez

Bioinformatician

dr. Joost Swennenhuis

Senior Scientist

Andre Verwei

CFO

Sara Astarita

Medical Associate

meet the full team

TEAM

Meet the team

Great science starts with great people. We are scientists, engineers, and thinkers who show up with curiosity, rigour, and a common purpose.

“Know the enemy and know yourself; in a hundred battles you will never be defeated”

— Sun Tzu (544 - 596 BC) - The Art of War

NEWS

Recent updates

  • Convention | BIO San Diego

    Read

  • Congress | EACR Budapest

    Read

  • Appointment | Mike Shaw as CBO

    Read

  • Round Table | HI-NL

    Read

  • Update | Processing our first blood samples

    Read

  • Seminar | Brigitte and Dr. Konstanze Wegener Seminar

    Read

  • Update | Our new FACS device

    Read

  • Interview | Sara Astarita

    Read

  • Update | Solve with Google Hackathon

    Read

  • Conference | ESMO

    Read

  • Interview | Joost Swennenhuis

    Read

  • Press release | Acquisition of Fetch B.V.

    Read

  • Interview | Alberto Gil Jimenez

    Read

  • Interview | Debora Meijer

    Read

  • Interview | Jenneke Wijling

    Read

Our partners

We are grateful to work alongside research & clinical partners who share our commitment to precision, innovation, and impact.

Our mission

We're always looking for scientists, engineers, and thinkers ready to help us defeat metastatic cancer.

Join our Mission